Clinical Trials Browser

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × Genitourinary × 30 days × Clear all

NCT06661122 2026-04-20

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06010914 2026-04-15

DADOX

Active not recruiting

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06392841 2026-04-08

HARMONY

Phase 2 Withdrawn

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)